Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 213

Note on left main disease – Medical therapy has not been addressed as a standalone therapy for left main disease in any contemporary trial. Old studies such as the VA-CABG trial and the CASS registry have shown that the mortality of medically treated left main disease, whether symptomatic or asymptomatic, is ~10% per year, with a dramatic reduction to 2% per year after CABG, the largest mortality benefit of CABG in any subgroup of patients.^101,102